The synthetic latex polymer (SLP) market in North America (United States, Canada, and Mexico) continues to benefit from trends that emerged during the COVID-19 pandemic.
With India having largely recovered from the COVID-19 pandemic, many of the country’s industry sectors are booming. Synthetic latex polymers will benefit from these trends, with India — which accounts for approximately 6% of global consumption and is the fastest-growing market for SLPs — reaping the rewards.
Consumers’ mounting health concerns, rapidly growing aging populations, the occurrence of chronic diseases, and the willingness to replace pharmaceutical agents are driving the market for nutraceutical actives in Europe and the United States.
The territories are two of the three key regional markets for nutraceutical actives, together accounting for around USD 8 billion; the U.S market is estimated to be higher in value.
Other reasons for the market increases include healthy lifestyles focusing on wellness, along with the rising number of gyms and fitness enthusiasts. Continue reading
Empty hard capsules (EHCs) are an effective alternative to the traditionally used tablet dosage forms in the pharmaceutical and nutrition industries. Despite having some disadvantages, such as higher costs and advanced technical requirements for manufacturing, hard capsules provide better dosage options for hygroscopic drugs, greater patient compliance, and are versatile dosage forms. Consequently, hard capsules were the second-leading oral solid-dosage form worldwide in 2020, after tablets. Continue reading
Biopharmaceuticals commonly called “biologics,” include a wide variety of products derived from human, animal, or microbial sources with the help of biotechnology. A surge of bio-APIs and their growing penetration into multiple therapies create an attractive market for pharmaceutical chemical suppliers.Continue reading
A surging number of biologic APIs and their growing penetration into multiple therapies create an attractive market segment for pharmaceutical ingredient suppliers but not one without challenges, analyzes Kline’s recently published Biologics: Market Opportunities for Chemicals Suppliers. To learn about key findings from the study, REGISTER for a complimentary webinar, taking place on October 17, 2019.
Currently, more than 350 biologics are commercially presented in the biopharmaceuticals market. Some established biologics, such as Humira and Avastin, maintained their growth of the last decade in 2018, with sales growing by 8.2% and 9.5%, respectively. New drugs such as Opdivo, which was first introduced in 2017, witnessed particularly robust growth in the overall biopharmaceutical market.Continue reading
The global pharmaceutical industry is facing a surge biologics. In recent years, biologic drugs have enjoyed a better approval rating than traditional drugs, as biologic drugs have been found to treat major chronic and complex diseases with higher safety and efficacy. The global production of biologics is expected to grow at a rate of around 10% annually.Continue reading
The market of synthetic latex polymers assumes a unique set of characteristics in every geography, from performance of the economy, purchasing power of the population, and industrialization to demand patterns, competition from alternate technologies, and performance of the polymers in specific end uses.
North America and China both represent the largest markets of synthetic latex polymers by volume, each accounting for an approximate 25% share of global consumption. Meanwhile, India, which has a much smaller share of around 5% of global consumption, is the fastest-growing market for synthetic latex polymers in the world. It is these three key geographical markets of North America, China, and India that Kline studies in depth this year in its continuous Synthetic Latex Polymers Global Series: Business Analysis and Opportunities program.Continue reading
By definition, excipients are inactive substances that serve as a medium or vehicle for pharmaceutical active drug substances. Over the years, excipients have been increasingly developed to provide important functionalities to pharmaceutical formulations. The global pharmaceutical market is worth more than USD 1.1 trillion as of 2017 and expected to grow more than 4% annually over the next five years. The global market of specialty excipients in the overall pharmaceutical industry is estimated at about USD 6.8 billion in 2017.Continue reading
The highly disruptive and rapidly growing additive manufacturing technology (AMT) promises a revolutionary change, not only in the large manufacturing industries, but also through average consumers. In addition to an economical alternative to traditional manufacturing, the 3D printing industry also provides the benefits of incorporating high levels of customization and complexity of design, as well as much lower lead times. This phenomenon of 3D printing, which until recently was mainly used for rapid prototyping, is now also increasingly being used in the production of end-parts and finished components in a wide range of applications, such as the automotive, aerospace, machine tools, electronics, medical, pharmaceuticals, and food industries.
3D printing has given rise to a rapidly growing multi-billion-dollar global market, offering highly profitable opportunities to companies along its supply chain. Continue reading